HealthInvest Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-335,000
| Closed | -$8.93M | – | 17 |
|
|
2021
Q3 | $8.93M | Sell |
335,000
-195,000
| -37% | -$5.2M | 13.38% | 2 |
|
|
2021
Q2 | $16.3M | Sell |
530,000
-4,000
| -0.7% | -$123K | 15.46% | 2 |
|
|
2021
Q1 | $14M | Buy |
534,000
+69,000
| +15% | +$1.81M | 11.13% | 2 |
|
|
2020
Q4 | $11.7M | Buy |
+465,000
| New | +$11.7M | 7.75% | 1 |
|
|
2017
Q1 | – | Sell |
-538,241
| Closed | -$13.6M | – | 15 |
|
|
2016
Q4 | $13.6M | Buy |
538,241
+158,708
| +42% | +$4.01M | 12.52% | 1 |
|
|
2016
Q3 | $9.39M | Sell |
379,533
-278,000
| -42% | -$6.88M | 6.98% | 11 |
|
|
2016
Q2 | $13.4M | Sell |
657,533
-246,000
| -27% | -$5.01M | 6.14% | 4 |
|
|
2016
Q1 | $13.8M | Sell |
903,533
-147,744
| -14% | -$2.25M | 6.45% | 6 |
|
|
2015
Q4 | $14.1M | Buy |
1,051,277
+268,531
| +34% | +$3.61M | 6.65% | 12 |
|
|
2015
Q3 | $11M | Buy |
+782,746
| New | +$11M | 6.5% | 9 |
|